drugset / Trial / NCT01107899

Study to Learn When Platelets Return to Normal After One Loading Dose of Anti-platelet Drugs in Patients With Symptoms of Acute Coronary Syndromes

NCT01107899

Phase 1 Terminated 29 enrolled Eli Lilly and Company Daiichi Sankyo · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate how platelets recover to normal function in subjects who have symptoms of a heart attack or unstable angina and who get a loading dose of prasugrel or clopidogrel for planned coronary angiography.

Timeline

Start
2009-10
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 600 mg Oral
Subject Prasugrel Small molecule 30 mg Oral
Subject Prasugrel Small molecule 60 mg Oral